Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma

NCT06583083 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

Interventions

DRUG: Sintilimab with P-GEMOX Regimen
DRUG: P-GEMOX Regimen

Sponsor

Sun Yat-sen University